Sugi Predict

Sugi Predict / Compounds / SCHEMBL247200

SCHEMBL247200

SCHEMBL247200

CC(C)CCOC(=O)CCCCCCCCC(=O)OCCC(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.57
▸ MAPT P10636 1/20 0.48
▸ DNM1 Q05193 1/20 0.47
▸ CYP19A1 P11511 1/20 0.46
▸ LMNA P02545 4/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ PAM P19021 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ DUSP3 P51452 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PRSS1 P07477 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493925 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL494939 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL493837 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL494601 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL494383 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL494198 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL495763 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL494501 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL249240 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA
SCHEMBL27998760 1.00 DGKA (0.57) DGKAMAPTDNM1CYP19A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12433831-B2 Silicone alternatives OLEON NV (BE) 2025-10-07 — — US claimed
CN-112437656-B Silicone substitute 欧荔安股份有限公司 2024-04-26 — — CN claimed
WO-2023067429-A1 LUBRICATING OIL COMPOSITION FOR HYBRID VEHICLES CHEVRON JAPAN LTD. (JP) 2023-04-27 — — WO claimed
US-20210161794-A1 SILICONE ALTERNATIVES OLEON NV (BE) 2021-06-03 — — US claimed
CN-112437656-A Silicone substitute 欧荔安股份有限公司 2021-03-02 — — CN claimed
CN-111012707-A Oil-in-water no-wash hair care emulsion containing hemp seed oil composite preparation 拉芳家化股份有限公司 2020-04-17 — — CN claimed
WO-2020035387-A1 SILICONE ALTERNATIVES OLEON NV (BE) 2020-02-20 — — WO claimed
EP-3610846-A1 SILICONE ALTERNATIVES Oleon N.V. (BE) 2020-02-19 — — EP claimed
EP-3089731-A1 SOLUBILISATION OF UV FILTERS Oleon (FR) 2016-11-09 — — EP claimed
WO-2015101752-A1 SOLUBILISATION OF UV FILTERS NOVANCE (FR) 2015-07-09 — — WO claimed
US-12605320-B2 Photoprotective composition comprising a glycine betaine derivative SURFACTGREEN (FR) 2026-04-21 — — US disclosed
US-20260047987-A1 BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR DAICEL CORPORATION (JP) 2026-02-19 — — US disclosed
US-12433831-B2 Silicone alternatives OLEON NV (BE) 2025-10-07 — — US disclosed
US-20250302727-A1 COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES LABORATOIRES M&L (FR) 2025-10-02 — — US disclosed
EP-4619109-A1 COSMETIC USE OF AN EXTRACT OF IMMORTELLE AS A SKIN LIGHTENING AGENT Laboratoires M & L (FR) 2025-09-24 — — EP disclosed
US-5382374-A Olefin oligomers, diester, phosphate friction modifier TONEN CORPORATION (JP) 1995-01-17 — — US disclosed
EP-0453114-A1 Hydraulic fluids for automobile suspensions Tonen Corporation (JP) 1991-10-23 — — EP disclosed
US-4719025-A WEAR RESISTANCE, DIESTER, POLYETHER TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 1988-01-12 — — US disclosed
US-4436844-A Process for the manufacture of a foundry core or mould AKZONA INCORPORATED (US) 1984-03-13 — — US disclosed
US-4110626-A Method for improving the quality of the fragrance of perfumes using aliphatic dibasic acid diesters SHISEIDO CO., LTD. (JP) 1978-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210161794-A1 SILICONE ALTERNATIVES CFD, MGMT, EIF2B5 DGKA 2774/4885MAPT 914/4885DNM1 4761/4885
US-20260047987-A1 BIODEGRADABLE SPHERICAL PARTICLES AND PRODUCTION METHOD THEREFOR PGA5, CD68, SBDS DGKA 2961/4885MAPT 4089/4885DNM1 4072/4885
US-20250302727-A1 COSMETIC USE OF A COMBINATION OF IMMORTELLE EXTRACTS TO REDUCE THE VISIBILITY OF SKIN PORES CUTA, IMMT, SYMPK DGKA 431/4885MAPT 2845/4885DNM1 1255/4885
US-12433831-B2 Silicone alternatives CFD, MGMT, EIF2B5 DGKA 2774/4885MAPT 914/4885DNM1 4761/4885
US-12605320-B2 Photoprotective composition comprising a glycine betaine derivative DEGS1, YWHAZ, EBP DGKA 40/4885MAPT 3584/4885DNM1 3121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.